Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.185,72
0,64%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aevi Genomic Medicine Inc (GNMX) Aevi Genomic Medicine Inc (GNMX) Notizie

GNMX

Aevi Genomic Medicine (GNMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GNMX
DataOraFonteTitoloSimboloCompagnia
14/02/202022:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202016:57Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:GNMXAevi Genomic Medicine Inc
14/02/202012:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202021:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202021:42Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/202021:40Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202018:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202018:58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNMXAevi Genomic Medicine Inc
07/02/202018:57Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202022:32Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202022:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNMXAevi Genomic Medicine Inc
03/02/202022:15GlobeNewswire Inc.Cerecor and Aevi Genomic Medicine Complete MergerNASDAQ:GNMXAevi Genomic Medicine Inc
06/01/202022:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GNMXAevi Genomic Medicine Inc
31/12/201922:47Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:GNMXAevi Genomic Medicine Inc
23/12/201913:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GNMXAevi Genomic Medicine Inc
16/12/201913:30GlobeNewswire Inc.NexImmune Appoints Sol Barer as Chairman of the Board of DirectorsNASDAQ:GNMXAevi Genomic Medicine Inc
11/12/201912:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GNMXAevi Genomic Medicine Inc
05/12/201914:45GlobeNewswire Inc.Cerecor to Acquire Aevi Genomic MedicineNASDAQ:GNMXAevi Genomic Medicine Inc
14/11/201914:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GNMXAevi Genomic Medicine Inc
15/10/201914:00PR Newswire (US)Aevi Genomic Medicine, Inc. Receives Positive Nasdaq Listing DeterminationNASDAQ:GNMXAevi Genomic Medicine Inc
07/08/201914:00PR Newswire (US)Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 AntibodyNASDAQ:GNMXAevi Genomic Medicine Inc
07/08/201912:04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GNMXAevi Genomic Medicine Inc
06/08/201923:12Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:GNMXAevi Genomic Medicine Inc
06/08/201914:00PR Newswire (US)Aevi Genomic Medicine to Present at the 2019 Wedbush PacGrow Healthcare ConferenceNASDAQ:GNMXAevi Genomic Medicine Inc
26/07/201923:19Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GNMXAevi Genomic Medicine Inc
15/07/201922:05PR Newswire (US)Aevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Gener...NASDAQ:GNMXAevi Genomic Medicine Inc
30/04/201914:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GNMXAevi Genomic Medicine Inc
29/03/201922:29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GNMXAevi Genomic Medicine Inc
12/02/201914:25GlobeNewswire Inc.Factors of Influence in 2019, Key Indicators and Opportunity within Park Hotels & Resorts, Planet Fitness, Aevi Genomic Medic...NASDAQ:GNMXAevi Genomic Medicine Inc
02/01/201922:30PR Newswire (US)Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children w...NASDAQ:GNMXAevi Genomic Medicine Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GNMX

La tua Cronologia

LBNK
DOGECOINUSDT
Buff Doge Coin
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network